OrthoSensor (Sunrise, FL) won FDA clearance for its VERASENSE device, an electronic wireless sensor used in place of tibial trial spacers during total knee replacement procedures to help guarantee proper alignment and balance. The device, which is compatible with a number of implants on the market, provides real-time feedback on its orientation and soft tissue balance as the new knee is being positioned.
Last year we spoke with Jay Pierce, the CEO of OrthoSensor about what the company is up to and how their technology was developed.
From OrthoSensor’s press release:
VERASENSE utilizes advanced, proprietary sensor and communications technologies to give surgeons real-time feedback on limb alignment, implant position and soft tissue balance during knee replacement. By delivering this dynamic, quantitative data, VERASENSE empowers surgeons to make evidence-based decisions regarding component placement, limb alignment and soft tissue balance to optimize clinical outcomes and enhance patient satisfaction.
VERASENSE integrates seamlessly within the current surgical workflow and is compatible for use with multiple knee implant systems. VERASENSE enables surgeons, for the first time, to rapidly make a total kinetic (force and motion) assessment of knee function and make adjustments to achieve balance and stability through a full range of motion.
Flashbacks: Q&A With Jay Pierce, CEO of OrthoSensor; Intelligent OrthoSensor Devices Provide Real-Time Reporting on The Condition of Your Orthopaedic Implant; OrthoSensor VERASENSE System Helps Perfect Total Knee Arthroplasties